PGNY News and Press, Progyny Inc. From 01/11/24

2024-01-11 09:08:40 ET More on Progyny Progyny Inc.: Resilient Business Model With Strong Growth Ahead Progyny: Market Underappreciating Excellent Quarter Seeking Alpha’s Quant Rating on Progyny For further details see: Progyny announces two leader...

NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced two newly created roles with the appointment of Katie Higgins as Chief Commercial Officer and Steven Leist as Chief Technol...

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 42 nd Annual J.P. Morgan Healthcare Co...

2023-12-22 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-19 05:10:00 ET Adding to your winning stocks can be one of the hardest but most important things to do when investing. After a strong market so far in 2023, there are plenty of investors sitting on an opportunity to do just that as they consider what investment actions to take in 20...

2023-12-16 09:20:57 ET Summary Progyny, Inc. demonstrates strong resilience and sustained growth potential in a weak macro backdrop. The company's revenue grew 37% year-over-year, beating estimates, with strong performance in fertility benefit services and pharmacy revenue. Th...

2023-12-15 09:47:07 ET Kyndryl Holdings Inc (KD) KD is trading DOWN for the last 4 days, and it at trading at $18.30 with volume of 377,869 and a one day change of $0.00 (-0.01%). Kyndryl Holdings Inc has a 52-week low of 10.49 and a 52-week high of $19.15. The business's 50-day mov...

2023-12-13 07:22:28 ET Summary The Liberty All-Star Growth Fund focuses on long-term capital growth and has an 8.02% current yield. The fund's share price has declined by 43.23% since June 2021, underperforming the S&P 500 Index. The fund offers exposure to small-cap stock...

2023-11-16 19:45:24 ET Summary Progyny's stock has under-performed the S&P this year, but the company's Q3 2023 results show potential for long-term growth. Progyny has a significant market opportunity with 8,000 self-insured employers and potential for 75 to 100 million cover...

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Offic...